Edan Instruments Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Edan Instruments.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth	26.7%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

There's Reason For Concern Over Edan Instruments, Inc.'s (SZSE:300206) Massive 28% Price Jump

Oct 01

Edan Instruments (SZSE:300206) Has Affirmed Its Dividend Of CN¥0.207

Apr 29

Why Investors Shouldn't Be Surprised By Edan Instruments, Inc.'s (SZSE:300206) 25% Share Price Plunge

Apr 18

Edan Instruments' (SZSE:300206) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 04

Edan Instruments, Inc.'s (SZSE:300206) Shares Bounce 28% But Its Business Still Trails The Market

Mar 04

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Edan Instruments has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:300206 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2024	1,796	156	235	291	N/A
6/30/2024	1,770	139	245	304	N/A
3/31/2024	1,742	119	141	192	N/A
12/31/2023	1,938	221	100	151	N/A
9/30/2023	2,024	280	268	308	N/A
6/30/2023	1,975	290	297	335	N/A
3/31/2023	1,993	324	305	347	N/A
1/1/2023	1,742	233	293	335	N/A
9/30/2022	1,614	170	60	141	N/A
6/30/2022	1,606	197	59	141	N/A
3/31/2022	1,515	156	118	192	N/A
12/31/2021	1,636	231	164	237	N/A
9/30/2021	1,687	268	386	419	N/A
6/30/2021	1,929	365	518	549	N/A
3/31/2021	2,470	696	632	667	N/A
12/31/2020	2,319	653	640	690	N/A
9/30/2020	2,212	655	425	486	N/A
6/30/2020	1,871	522	259	318	N/A
3/31/2020	1,226	176	90	158	N/A
12/31/2019	1,136	132	62	115	N/A
9/30/2019	1,084	117	110	152	N/A
6/30/2019	1,048	112	75	121	N/A
3/31/2019	1,029	104	54	90	N/A
12/31/2018	993	93	46	82	N/A
9/30/2018	941	65	27	59	N/A
6/30/2018	912	58	N/A	75	N/A
3/31/2018	877	44	N/A	107	N/A
12/31/2017	843	44	N/A	114	N/A
9/30/2017	824	83	N/A	69	N/A
6/30/2017	792	53	N/A	45	N/A
3/31/2017	747	46	N/A	9	N/A
12/31/2016	698	26	N/A	-45	N/A
9/30/2016	661	99	N/A	11	N/A
6/30/2016	612	120	N/A	25	N/A
3/31/2016	589	125	N/A	52	N/A
12/31/2015	550	103	N/A	28	N/A
9/30/2015	546	18	N/A	-30	N/A
6/30/2015	532	4	N/A	-30	N/A
3/31/2015	509	-8	N/A	-26	N/A
12/31/2014	523	13	N/A	8	N/A
9/30/2014	494	15	N/A	34	N/A
6/30/2014	486	29	N/A	34	N/A
3/31/2014	473	33	N/A	22	N/A
12/31/2013	455	35	N/A	30	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 300206's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 300206's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 300206's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 300206's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 300206's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 300206's Return on Equity is forecast to be high in 3 years time

Edan Instruments Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Edan Instruments, Inc. Unveils Latest Innovations for Global Healthcare at MEDICA 2024

Third quarter 2024 earnings released: EPS: CN¥0.081 (vs CN¥0.051 in 3Q 2023)

Investor sentiment deteriorates as stock falls 16%

There's Reason For Concern Over Edan Instruments, Inc.'s (SZSE:300206) Massive 28% Price Jump

Edan Instruments, Inc. to Report Q3, 2024 Results on Oct 25, 2024

Investor sentiment improves as stock rises 27%

Now 21% overvalued after recent price rise

Edan Instruments, Inc. to Report First Half, 2024 Results on Aug 30, 2024

Edan Instruments (SZSE:300206) Has Affirmed Its Dividend Of CN¥0.207

Dividend of CN¥0.21 announced

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: EPS: CN¥0.066 (vs CN¥0.24 in 1Q 2023)

Why Investors Shouldn't Be Surprised By Edan Instruments, Inc.'s (SZSE:300206) 25% Share Price Plunge

Edan Instruments' (SZSE:300206) Weak Earnings May Only Reveal A Part Of The Whole Picture

Edan Instruments, Inc. to Report Q1, 2024 Results on Apr 26, 2024

Edan Instruments, Inc., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings released: EPS: CN¥0.38 (vs CN¥0.40 in FY 2022)

Investor sentiment improves as stock rises 33%

Edan Instruments, Inc.'s (SZSE:300206) Shares Bounce 28% But Its Business Still Trails The Market

Investor sentiment deteriorates as stock falls 16%

Edan Instruments, Inc. to Report Fiscal Year 2023 Results on Mar 29, 2024

Edan Instruments, Inc. Focus on Medical Technology Advancement Shines At Medica 2023

Third quarter 2023 earnings released: EPS: CN¥0.051 (vs CN¥0.068 in 3Q 2022)

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.17 in 2Q 2022)

Edan Instruments, Inc. to Report First Half, 2023 Results on Aug 23, 2023

First quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.085 in 1Q 2022)

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: CN¥0.068 (vs CN¥0.11 in 3Q 2021)

Edan Instruments, Inc. Showcases Its First Molecular Diagnostics Analysis System, ClariLight CL30, at Medlab Asia & Asia Health 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.10 in 2Q 2021)

Edan Instruments, Inc. Launches i20

High number of new directors

High number of new directors

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Edan Instruments, Inc. Announces Cash Dividend for the Year 2021, Payable on 29 April 2022

Edan Instruments, Inc. Approves Distribution for 2021

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.28 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.10 (vs CN¥0.67 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.14 in 1Q 2020)

Edan Instruments, Inc. Announces Profit Distribution Proposal for 2020

Full year 2020 earnings released: EPS CN¥1.12 (vs CN¥0.23 in FY 2019)

New 90-day high: CN¥19.94

Investor sentiment improved over the past week

New 90-day low: CN¥16.31

Edan Instruments, Inc. to Report Fiscal Year 2020 Results on Mar 15, 2021

New 90-day low: CN¥16.65

New 90-day low: CN¥16.72

New 90-day low: CN¥19.12

Third quarter earnings released

Edan Instruments, Inc. to Report Q3, 2020 Results on Oct 27, 2020

First half earnings released

Edan Instruments, Inc. to Report First Half, 2020 Results on Aug 21, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies